Article
The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Scientific reports - 9 Sept 2021
Ngamkam Jaruwan, Vadcharavivad Somratai, Areepium Nutthada, Auamnoy Titinun, Takkavatakarn Kullaya, Katavetin Pisut, Tiranathanagul Khajohn, Praditpornsilpa Kearkiat, Eiam-Ong Somchai, Susantitaphong Paweena
Abstract excerpt
The objective of this study was to determine the impact of calcium sensing receptor (CASR) A990G genetic polymorphism on parathyroid hormone (PTH) lowering response to cinacalcet treatment when controlling for significant influencing clinical factors. This retrospective study was conducted on 135 Thai hemodialysis (HD) patients with secondary hyperparathyroidism (SHPT). CASR A990G genotypes were determined. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
